View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pall Corporation
3 January 2019

Gene Therapy Manufacturing: Accelerate Development, Simplify Your Process

Pall Biotech has announced a new end-to-end integrated platform solution that accelerates development, reduces risk and simplifies your process for gene therapy manufacturing.

The company provides a fully integrated, scalable, and single-use gene therapy solution from development through to commercialisation, from upstream and downstream processing through to formulation and filling.

Key features include:

  • Simplify and streamline your process while reducing the risk for operator error
  • Reduce time-to-market
  • Reduce overall cost of goods

A presentation explaining this feature is available. Depending on your preference, Pall Biotech can arrange for an on-site visit by one of its technical specialists or a presentation can be delivered via webex.

Contact the company using the enquiry form for more information.

Selecting the right filter integrity test instrument is an important task. An informed, balanced choice will support seamless integration of the instrument into critical processes...
Founded by Dr David B Pall in 1946, Pall Corporation has grown from a company producing filters for the airline industry to a global innovator...
Recent advances in personalised regenerative medicine have been significant. However, further developments are needed to support market and regulatory demands, particularly the development of manufacturing...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology